Related Experiment Video
Updated: Jun 17, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
Denoising Drug Discovery Data for Improved Absorption, Distribution, Metabolism, Excretion, and Toxicity Property
Matthew Adrian1, Yunsie Chung1, Alan C Cheng1
1Modeling and Informatics, Merck & Co., Inc., South San Francisco, California 94080, United States.
Abstract:
Predicting absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties of small molecules is a key task in drug discovery. A major challenge in building better ADMET models is the experimental error inherent in the data. Furthermore, ADMET predictors are typically regression tasks due to the continuous nature of the data, which makes it difficult to apply existing denoising methods from other domains as they largely focus on classification tasks. Here, we develop denoising schemes based on deep learning to address this. We find that the training error (TE) can be used to identify the noise in regression tasks while ensemble-based and forgotten event-based metrics fail to detect the noise. The most significant performance increase occurs when the original model is finetuned with the denoised data using TE as the noise detection metric. Our method has the ability to improve models with medium noise and does not degrade the performance of models with noise outside this range (low noise and high noise regimes). To our knowledge, our denoising scheme is the first to improve model performance for ADMET data and has implications for improving models for experimental assay data in general.
More Related Videos
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
10:21Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
Published on: February 23, 2024
Related Concept Videos
Drug Discovery: Overview
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Analysis of Population Pharmacokinetic Data
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
Drug-Receptor Interaction: Antagonist
Antagonists can be classified as competitive or noncompetitive based on their...